MedPacto Inc

235980

Company Profile

  • Business description

    MedPacto Inc is a drug discovery and development company based in South Korea. It is engaged in developing anticancer drugs and medicines which focuses on therapeutics targeting cancer and autoimmune diseases. Its products are in pipeline.

  • Contact

    92 Myeongdal -ro
    Seocho-gu, Borim Building
    Seoul
    KOR

    T: +82 269380200

    http://www.medpacto.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    56

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,321.1010.80-0.12%
CAC 408,243.8415.02-0.18%
DAX 4024,316.2513.78-0.06%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,514.3287.330.93%
HKSE25,781.77245.78-0.94%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,307.798.27-0.02%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,735.350.220.00%
S&P/ASX 2009,030.0010.30-0.11%
SSE Composite Index3,913.762.57-0.07%

Market Movers